The best indicator for Boston Scientific (BSX)
We backtested 382 indicators across daily, weekly and hourly charts on real Boston Scientific (BSX) history. Here's what actually worked — risk-adjusted over the full backtest, with costs, and checked out-of-sample.
Where Boston Scientific (BSX) stands
Computed from our own daily OHLCV history, not quoted from a third party. Moving averages use closing prices; "52-week" is the last 252 trading sessions.
CCI (100)
On the weekly chart, this is the strongest risk-adjusted edge we found for Boston Scientific (BSX) over ~34.5 years — beating buy-and-hold by 4.7% CAGR.
Boston Scientific (BSX) on the weekly chart
The timeframe our backtest found best for this asset. The chart is live market data; the results above are hypothetical and historical.
Chart by TradingView. Loading it contacts tradingview.com, which may set its own cookies — see our privacy policy.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Boston Scientific (BSX) — trailing buy-and-hold by 0.5% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | CCI (100) ✓ | Weekly | 11.5% | 0.58 | -53.3% | 38.9% | 18 | 4.7% |
| 2 | DEMA 200 Trend ✓ | Weekly | 8.4% | 0.57 | -37.7% | 45.8% | 24 | 1.6% |
| 3 | TRIMA 100 Trend ✓ | Weekly | 11.4% | 0.59 | -61.3% | 50.0% | 14 | 4.6% |
| 4 | EMA 100 Trend ✓ | Weekly | 10.7% | 0.54 | -55.4% | 30.8% | 26 | 3.9% |
| 5 | Disparity (100) ✓ | Weekly | 10.7% | 0.54 | -55.4% | 30.8% | 26 | 3.9% |
| 6 | Bollinger Squeeze ✓ | Weekly | 8.0% | 0.53 | -40.2% | 51.9% | 27 | 1.2% |
| 7 | G-Channel ✓ | Weekly | 10.4% | 0.53 | -50.6% | 41.9% | 31 | 3.6% |
| 8 | MA Ribbon ✓ | Weekly | 8.5% | 0.52 | -65.0% | 40.7% | 27 | 1.7% |
| 9 | SMA 100 Trend ✓ | Weekly | 9.9% | 0.52 | -55.4% | 44.4% | 27 | 3.1% |
| 10 | WMA 100 Trend ✓ | Weekly | 9.7% | 0.52 | -62.4% | 40.0% | 30 | 2.9% |
| 11 | RSI (50) ✓ | Weekly | 10.2% | 0.52 | -55.4% | 31.0% | 29 | 3.3% |
| 12 | Keltner 50 (x2.0) ✓ | Weekly | 7.2% | 0.52 | -46.6% | 45.5% | 55 | 0.4% |
| 13 | T3 15/60 Cross ✓ | Daily | 9.6% | 0.5 | -68.8% | 47.7% | 65 | 2.6% |
| 14 | Linear Regression Slope ✓ | Weekly | 9.9% | 0.5 | -59.1% | 48.7% | 39 | 3.1% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
What it would take to beat buy & hold on Boston Scientific (BSX)
21 of 679 tested setups beat buy-and-hold on Boston Scientific (BSX) outright. Another 266 could get there with leverage they would survive — but 180 would be liquidated by their own drawdown before they caught it.
| Indicator | Beats B&H unlevered | Leverage needed | Leverage survived |
|---|---|---|---|
| ALMA 200 Trend | 1 | 2.1× | 2.35× |
| WMA 20/50 Cross | 1 | none needed | 4.17× |
| TRIX | 1 | none needed | 2.5× |
| True Strength Index | 1 | none needed | 2.99× |
| Relative Vigor Index | 1 | none needed | 2.18× |
| Chaikin Money Flow | 1 | none needed | 2.52× |
Out-of-sample, costs included. A setup is only listed if the leverage it needs is less than the leverage its own worst drawdown survives — when it isn't, no amount of leverage gets there. Volatility drag isn't modelled, so these are the optimistic case. Every indicator, ranked this way
For Boston Scientific (BSX), CCI (100) on the weekly timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get alerted when Boston Scientific’s signal flips
We track Boston Scientific daily. Its backtested best indicator, CCI (100) (Weekly), is flat right now — we'll email you the moment that changes. Free, no spam, unsubscribe any time.